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1. Introduction 
Cerebral ischemic events from trauma, stroke, hemorrhagic shock, or other cerebral 
perfusion deficit, initiate a cascade of detrimental processes leading to long lasting tissue 
injury and poor neurological outcome. Correction of the perfusion deficit is vital. However, 
no interventions have been identified that protect compromised cerebral tissue during the 
resolution of the ischemic event. 
This chapter reviews two emerging concepts: preconditioning, which may have therapeutic 
utility for the protection of patients for planned treatments such as surgical intervention, and 
postconditioning, which may have benefits for amelioration of deficits from ischemic events, 
vascular injury and accidents. Preconditioning (described below) was first described from 
maneuvers that induced cytoprotection by temporarily occluding vessels serving the tissue 
or region of interest. There are inherent risks in performing such a maneuver, so that 
pharmacological agents—particularly for delayed preconditioning (described later)—affecting 
the aforementioned signal transduction and genomic pathways, are a safer, more realistic 
area of study. Conditioning is still primarily an experimental phenomenon. However, 
investigators have made considerable strides in uncovering the multiple, albeit complex 
signal transduction pathways that mediate conditioning effects. This knowledge may help 
clinicians one day develop schemes for neuroprotection. 
2. Ischemic preconditioning: Origins in cardiology 
The preconditioning concept has roots in cardiovascular research. Ischemic preconditioning 
was originally described in a landmark 1986 study by Murry and associates (Murry, et al., 
1986). Using a cardiac dog model, these investigators found that multiple, brief ischemic 
episodes protected the heart from a subsequent sustained ischemic insult. An experimental 
group of dogs experienced circumflex artery occlusion for 5-minute intervals with 5-minute 
reperfusions. This cycle was repeated a total of four times—clamping for 5 minutes and 
unclamping for 5 minutes. The circumflex artery was then clamped for 40 minutes. The 
control group of dogs had their circumflex artery occluded for 40 minutes. Surprisingly, 
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despite the additional 20 minutes of ischemia in the preconditioned animals, cardiac 
damage, measured by infarct size, was significantly reduced to just ¼th of the infarct 
observed in the hearts of dogs in the control group. This paper was the first to demonstrate 
and coin the term, ischemic preconditioning. 
2.1 Preconditioning 
Preconditioning has been demonstrated in all species studied to date (rat, mouse, rabbit, 
dog, human, chicken, sheep, pig and including cell lines), and in all organs studied thus far, 
including skeletal muscle, brain, kidney, small intestine, heart, and liver (Peralta, et al., 1996; 
Glazier, et al., 1994; Pang, et al., 1995). Other preconditioning manipulations, such as global 
hypoxia (Emerson, et al., 1999) and thermal injury (Marber, et al., 1993), are also effective in 
protection from lasting insult. Prior to this 1986 discovery, the best pharmacological 
treatments (with varying reproducible results) for the protection of cardiac muscle from 
infarction only preserved 10-20% of tissue compared to the 75% protection afforded by 
preconditioning (Yellon & Downey, 2003). 
Research has determined that ischemic preconditioning can be subdivided into two 
distinctive types; classical and delayed. In classical preconditioning, the protective effects of 
ischemia/perfusion cycles are evident within minutes after the insult and persist for 2-3 
hours (Ishida, et al., 1997). Classical preconditioning is independent of protein synthesis, 
and is therefore dependent upon existing cellular pathways. It involves the direct 
modulation of energy supplies, pH regulation, Na+ and Ca2+ homeostasis and caspase 
inactivation (Carini, & Albano, 2003). Investigations have shown many triggers can activate 
classical ischemic preconditioning, including agonists of G protein-coupled receptors 
[bradykinin (Goto, et al., 1995), opioids (Schultz, et al., 1998), norepinephrine (Hu & Nattel, 
1995), adenosine (Liu, et al., 1991), potassium ATP channel (KATP) openers, such as 
diazoxide, pinacidil (Legtenberg, et al., 2002), succinate dehydrogenase inhibitors, such as 3-
nitropropionic acid (Ockaili, et al., 2001), and volatile anesthetics, such as sevoflurane and 
isoflurane (Zaugg, et al., 2002)]. 
With classic preconditioning, a trigger event, such as brief ischemia, activates a number of 
intracellular pathways that lead to the protected cell phenotype. The actual sequence of 
these pathways has not been determined, but some components of the cascade have been 
identified. G-coupled receptors, for example, activate the epsilon (ε) isoform of protein 
kinase C (PKC-ε; Mitchell, et al., 1995; Kilts, et al., 2005), which has been implicated as the 
key PKC subtype involved in preconditioning. Also important is the upstream signaling 
molecule, phosphatidylinositol-3-kinase (PI3K; Tong, et al., 2000), and mitogen-activated 
protein kinases (MAPKs; Armstrong, 2004). PI3K activates the serine/threonine kinase, Akt, 
which inactivates the pro-apoptotic kinase glycogen synthase kinase-3 (GSK-3) via 
phosphorylation (Tong, et al., 2002). Phosphorylation of GSK-3, in turn, inhibits the opening 
of the mitochondrial permeability transition pore (mPTP). Cell apoptosis or necrosis often 
occurs during reperfusion due to opening of the mPTP, a large nonselective pore traversing 
both inner and outer membranes of mitochondria. Cytochrome c and apoptotic-inducing 
factor (AIF) are both released through the mPTP during ischemic reperfusion, leading to the 
activation of caspase and caspase-independent apoptotic pathways (Kadenbach, et al., 2011; 
Penninger, & Kroemer, 2003). KATP channels are key intracellular triggers of early ischemic 
preconditioning. This channel will be described in more detail later in this chapter. 
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Although not as effective as classical preconditioning, delayed or late preconditioning 
becomes apparent approximately 24 hours after initial preconditioning and it can persist for 
up to 72 hours (Ishida, et al., 1997). The most significant difference between classical and 
delayed preconditioning is the latter’s requirement of the manufacture of new proteins 
needed to obtain protection; inhibition of new protein synthesis attenuates the protection 
derived from delayed preconditioning (Rizvi, et al., 1999). 
The triggers for delayed preconditioning are similar to classical preconditioning. These 
include cellular stress factors (sub-lethal ischemia, heat stress, cardiac pacing), which release 
factors such as reactive oxygen species, adenosine, and endogenous nitric oxide (NO). NO 
has been determined to have no effect on classical preconditioning and is a trigger specific 
only for delayed preconditioning (Bolli, 2000). Endogenous preconditioning agents also 
initiate delayed preconditioning and include adenosine agonists, bradykinin, opioids, NO 
donors, acetylcholine and norepinephrine (Bolli, 2000). Exogenous agents that activate the 
preconditioning pathways include, diazoxide, nicorandil, some hypercholesterolemic 
agents, and volatile anesthetics (Gross, 2005). 
Kinase intracellular pathways play a central role in delayed preconditioning, with activation 
of the PKC-ε isoform being particularly essential. Downstream to PKC-ε, tyrosine kinases 
and other kinases then activate the important transcription factor, NF-κB, which leads to the 
upregulation of many protective proteins in the nucleus. Some key proteins identified thus 
far include: inducible NO synthase (iNOS) (Takano, et al., 1998, cyclooxygenase (COX-2) 
(Shinmura, et al., 2000), the antioxidant enzyme superoxide dismutase (SOD) (Hoshida, et 
al., 2002), and heat shock proteins, HSP70, HSP25, and HSP32 (Bolli, 2000). Delayed 
preconditioning also reduces apoptosis by upregulating the anti-apoptotic protein, Bcl-2, 
which has been shown to inhibit opening of the mPTP, leading to cell survival (Maulik, et 
al., 1999). Mitochondrial KATP (mKATP) channel opening seems to be the final common 
pathway for these signaling pathways but it is not yet clear how the opening of these 
channels affords protection. Delayed preconditioning requires the opening of the mKATP 
channels during the ischemic event; its role after 24 hours, when delayed preconditioning 
occurs, is less clear (Takano, et al., 2000). 
By 1993, an appreciable number of studies had confirmed that the direct application of 
various stimuli (hypoxia, ischemia, triggering agents) resulted in tissue and organ 
protection. In that year, however, Przyklenk and colleagues made a startling discovery. 
Using a canine model in which the circumflex artery was occluded (as in Murry’s 1986 
study), Przyklenk and colleagues observed that cardiac muscle supplied by the descending 
left coronary artery was also protected from ischemic insult, indicating that the 
preconditioning stimulus offered protection that was not confined to one area of an organ 
(Przyklenk, et al., 1993). Further experiments have shown remote classical ischemic 
preconditioning also is effective in other organs. A preconditioning trigger in one area of an 
organ offers protection to a different region of that same organ or to a different organ. For 
example, one group demonstrated that intermittent tourniquet application to a hind limb 
(ischemic preconditioning) implemented protection in other skeletal muscles (Addison, et 
al., 2003). Remote classical preconditioning of the heart was also obtained via transient 
ischemia of the small intestine (Liem, et al., 2005; Patel, et al., 2002) or the kidney (Gho, et al., 
1996). Other studies have demonstrated remote delayed preconditioning. Induction of small 
intestine ischemia, for example, engenders myocardial protection 24-72 hours later (Wang, 
et al., 2001; Xiao, et al., 2001). 
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The precise mechanism of remote ischemic preconditioning is unknown, but putative factors 
have been identified. Protection from kidney or intestinal preconditioning on cardiac muscle 
was eliminated with application of the ganglionic blocker, hexamethonium, suggesting 
involvement of a neuronal pathway (Gho, et al., 1996). However, stronger evidence exists 
that a humoral factor may play a more important role. Effluent from a preconditioned heart, 
transferred by whole blood transfusion, protected a non-conditioned heart from ischemic 
insult (Dickson, et al., 1999a; 1999b). Remote preconditioning was not activated by 
adenosine or bradykinin, but was found to be attenuated by the opioid antagonist, 
naloxone, suggesting opioid receptor involvement (Dickson, et al., 2001). 
2.2 Postconditioning 
One promising approach for neuroprotective therapies may be derived from 
postconditioning, where supportive measures are employed following an injury. 
Postconditioning is very similar to preconditioning with the exception of the temporal 
relationship of the protective maneuver in respect to the prolonged period of ischemia. 
Preconditioning is an intervention that occurs prior to injury while postconditioning 
interventions occur after an injury has occurred and thus may be more clinically relevant. 
The origin of postconditioning stems from the work of Okamoto and colleagues (Okamoto, 
et al., 1986). Okamoto’s group established that post-ischemic damage could be limited by 
the use of timely low-pressure reperfusion. Following a period of ischemia, dog hearts were 
reperfused either with the sudden release of a coronary occlusion, or by low-pressure (40 to 
50 mm Hg) coronary reperfusion with normal blood for 20 minutes before completely 
removing the coronary occlusion. This maneuver focused on the initial stage of reperfusion 
and established the basis for novel postconditioning approaches to resuscitation. Years later, 
Mizumura et al. (1995) first demonstrated pharmacological postconditioning. Mizumura’s 
group used the KATP channel opener, bimakalin. Bimakalin markedly reduced cardiac 
infarct size in dogs when given 10 minutes before and during the 60-minute coronary 
reperfusion period following a set time of occlusive hypoxia. Collectively, these initial 
findings firmly established the concept of postconditioning and emphasized a critical factor 
that altering the initial moments of reperfusion was beneficial. 
In 2003, Zhao and colleagues (2003) first used the term postconditioning. They found in a model 
of occlusive hypoxia in dogs that short, repeated (or stuttered) periods of arterial occlusion and 
release of previously occluded coronary arteries (three occlusions of 30 seconds each) prior to 
restoration of perfusion reduced infarct area by 44% as compared to controls. This was an 
example of a mechanical postconditioning intervention and implied that the first minute of 
reperfusion is critical in thwarting cellular demise. These findings were further validated by 
Kin et al. (2004). Kin and colleagues stated that the first minute of reperfusion in the rat was 
crucial for postconditioning. Three cycles of 10 seconds of coronary occlusion and 10 seconds 
of coronary release, preceding a full coronary occlusion release, decreased cardiac infarct size 
by 23%. In the broadest sense, the cellular processes activated by postconditioning are 
analogous to those activated by preconditioning, and the sole difference between the two 
interventions is the timing related to the prolonged period of ischemia. 
3. Signaling processes linked to preconditioning and postconditioning 
Many studies have investigated the mechanism of postconditioning with the aspiration to 
utilize this powerful protective system in the clinical setting. Recent observations from the 
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employment of mechanical and pharmacological postconditioning suggest the activation of 
mitochondrial KATP (mKATP) channels initiates a series of events that close the mitochondrial 
permeability transition pore (mPTP) and converge onto the Reperfusion Injury Survival 
Kinase (RISK) Pathway. 
3.1 KATP channels 
KATP channels were first discovered in 1983 by A. Noma in a patch clamp study using 
cardiac muscle membrane preparations (Noma, 1983). There are cell surface KATP (sKATP) 
and mitochondrial KATP (mKATP) forms. Pharmacologically, these are different channels, but 
their opening (via PKC or pharmacological agents) leads to increased cell survival. One 
hypothesis is that activation of KATP channels hyperpolarizes the cell membrane thereby 
protecting the cell from detrimental depolarization (Kirino, 2002). In 1997, Garlid and 
coworkers presented evidence that mKATP channels have a cardioprotectve role in ischemia 
and reperfusion, and were a component in the mechanism for preconditioning (Garlid, et al., 
1997). A prototypical mKATP channel, as reviewed by Aguilar-Bryan and Bryan (1999), is an 
octameric structure consisting of four sulfonylurea receptor (SUR1 or SUR2) subunits and 
four K+ inward-rectifying (Kir6.1 or Kir6.2) subunits. Attached to the SUR subunits are two 
nucleotide binding domains (NBD). The mKATP channel is activated in low energy states by 
ADP, binding to NBDs, allowing the influx of K+ into the mitochondrial inner matrix. 
Conversely, the mKATP channel is inhibited in high energy states when ATP closes the Kir 
channel. In the brain, it appears the predominant subtypes are SUR2 and Kir6.2, although 
the SUR1 and Kir6.1 subunits are present in smaller amounts (Lacza, et al., 2003). The mKATP 
channel may trigger preconditioning or postconditioning via mechanisms dependent on 
matrix volume stabilization, respiratory inhibition, controlled production of reactive oxygen 
species (ROS), and the closure of the mPTP. 
The physiological functions of mKATP channels have been debated. The activities of the 
mKATP channel and the K+/H+ exchanger are believed to maintain K+ homeostasis within 
mitochondria by controlling mitochondrial volume and moderating the outer-to-inner pH 
gradient needed to drive ATP synthesis. In the presence of hypoxia, whole cell pH decreases 
and ATP production declines. This causes a switch to anaerobic metabolism. A decrease in 
pH combined with an increase in the AMP/ADP ratio secondary to ATP metabolism causes 
the mKATP channel to open allowing the influx of K+ into the inner matrix. This, in turn, 
activates the K+(out)/H+(in) exchanger decreasing the hydrogen gradient between the outer 
membrane and inner matrix (Szewczyk & Marbán, 1999). By doing so, the proton motive 
forces driving ATP production are attenuated and mitochondria energetics slow. During 
this time, the mPTP is closed as membrane stability and electrical potential are better 
maintained by the simultaneous activity of the mKATP channel and the K+/H+ exchanger. In 
addition, reactive oxygen species (ROS) generation is proportional to the availability of 
oxygen and activation of mKATP channel appears to moderate ROS production (Ferranti, et 
al., 2003; Saitoh, et al., 2006). However, this effect is only protective to a limited extent. For 
example, a moderate or controlled production of ROS signals promote prosurvival signaling 
while excessive ROS production promotes apoptotic signaling. 
As anaerobic metabolism continues in response to an extended period of severe hypoxia, 
ATP hydrolysis exceeds ATP generation causing a dramatic rise in H+ within the cell and 
mitochondrial inner matrix. At some point H+ entry becomes lethal as it exceeds the 
outward pumping capacity of the mitochondrial electron transport chain already hindered 
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by anaerobic metabolism. This results in a total loss of proton motive force driving ATP 
production. If prolonged, this loss results in osmotic matrix swelling, mitochondrial 
degradation, and release of apoptotic proteins such as cytochrome C. 
Upon resolution of a perfusion defect, abrupt reperfusion following prolonged ischemia 
results in a substantial amount of ROS generation. Following restoration of flow to intact but 
vulnerable cells, ATP levels begin to rise, mKATP channels close and K+ transport into the 
mitochondrial matrix declines. This indirectly decreases the activity of the K+/H+ exchanger. 
As H+ ions are rapidly removed from the matrix during mitochondrial respiration, the inner 
matrix quickly alkalinizes, causing the mPTP to open (Vinten-Johansen, et al., 2007). 
Opening the mPTP rapidly elevates inner matrix osmotic pressure leading to matrix 
distension and if allowed to remain open, mitochondrial rupture. 
In total, mKATP channel closure associated with abrupt reperfusion cand result in the 
significant elevation of ROS and increase the mitochondrial inner matrix osmotic pressure, 
causing the mitochondria to quickly swell or rupture, releasing apoptotic factors such as 
cytochrome C (Armstrong, 2004). It is reasonable to suggest that maintaining the patency of 
the mKATP channel would be beneficial during reperfusion. Allowing the mKATP channel to 
remain open during reperfusion could: 1) moderate the generation of ROS, 2) reduce 
osmotic force within the matrix by promoting ion exchange, and 3) reduce the activity of the 
mPTP thereby providing a protective effect. 
Activation of mKATP channels have been shown to be protective during reperfusion in 
cardiac and brain tissue (Obal, et al., 2005; O’Sullivan, et al., 2007; Penna, et al., 2007; Wu, et 
al., 2006). Obal and colleagues (2005), for example, demonstrated the utility of inhaling 
volatile anesthetics as a postconditioning trigger through mKATP channel activation. In rats 
subjected to cardiac ischemia, postconditioning was invoked by administering 1 minimum 
alveolar concentration (MAC) of sevoflurane for 2 minutes with the onset of reperfusion. 
This resulted in a significant decrease in cardiac infarct size. Penna et al. (2007, isolated rat 
hearts and exposed them to an ischemic period followed by reperfusion. Their results 
suggested that postconditioning mechanisms are activated by a bradykinin or a diazoxide 
mechanism resulting in the upregulation of protein kinase G (PKG). This upregulation was 
dependent on early ROS generation triggered by mKATP channel activation. They 
emphasized that their results were different from mechanical manipulations by showing 
that pharmacological agents, such as bradykinin or diazoxide, administered during the 
reperfusion period could induce protection. ROS also regulate the activity of heat shock 
proteins (HSPs). Using an in vitro vascular smooth muscle preparation, Madamanchi and 
colleagues (2001) discovered that the application of H2O2 significantly upregulated HSP70. 
3.2 mPTPs 
As previously mentioned, the mPTP is inhibited with the activation of mKATP. The existence 
of the mPTP was confirmed in 1992 in rat liver mitoblast membranes (Szabó & Zoratti, 
1992). The primary components of the mPTP are the voltage-dependent anion channel in the 
outer membrane, the adenine nucleotide translocator, and the cyclophilin D protein within 
the matrix (Lin & Lechleiter, 2002). In general, it is thought that the opening of the mPTP 
occurs with a decrease in the inner matrix potential, decreased AMP and ADP levels, 
increased matrix Ca2+, with alkalinization, or during oxidative stress (Gateau-Roesch, et al., 
2006). mPTP opening blocks ATP formation and allows for the equilibration of small 
molecules (Gateau-Roesch, et al., 2006; Halestrap, 2004). mPTP opening increases osmotic 
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forces within the mitochondria inner matrix and leads to degradation of the matrix 
membrane, causing the release of apoptotic factors, especially cytochrome C (Honda, et al., 
2005). Also, as the mitochondrial membrane potential is perturbed, ATP synthase reverses 
its primary function and serves as an ATPase; further depleting cellular ATP concentrations 
and increasing H+ levels. 
Feng and colleagues (2005) determined that volatile anesthesia-induced postconditioning 
prevented the opening of the mPTP by inhibiting glycogen synthase kinase 3β (GSKβ). This 
inactivation was a result of PI3K-AKT signaling pathway inactivation with the resulting 
phosphorylation and inactivation of GSKβ, which protected against reperfusion damage. 
Argaud et al. (2005) found that mechanical postconditioning decreased cellular Ca2+ and 
protected in vivo rabbit hearts, suggesting that the mPTP could be inhibited by the PI3K-
AKT-eNOS cascade. Bopassa et al. (2006), using a rat heart preparation undergoing 
postconditioning, concluded that PI3K signaling regulates the closure of mPTP. In addition, 
Cohen, Yan, and Downey (2007) observed that postconditioning prevented mPTP opening 
as a result of inhaled CO2-induced acidosis during the first minutes of reperfusion. They 
suggested that low cellular pH inhibits the opening of mPTP in heart tissue, but as the 
cellular pH normalizes, the inhibition of mPTP is lost. They hypothesized that by 
maintaining the cellular pH at a lower level while introducing oxygen during reperfusion, it 
was possible to keep the mPTP closed allowing the redox signaling necessary to trigger 
preconditioning-like protection. Cohen, Yan, and Downey further suggest that moderate 
acidosis during reperfusion might be protective. This hypothesis was addressed through the 
use of sodium bicarbonate (NaHCO3) during postconditioning. In isolated rabbit hearts, 
acidic CO2 perfusate at the time of reperfusion mimicked postconditioning while an alkaline 
NaHCO3 perfusate blocked that effect. They hypothesized that an acidic environment 
inhibited mPTP opening while an alkaline environment favored mPTP opening. Fujita and 
colleagues (2007) also hypothesized that NaHCO3 would blunt the protective properties of 
postconditioning. Using in vivo dog hearts that underwent ischemia, the administration of 
NaHCO3 during four intermittent cycles of one-minute reperfusion with one-minute 
reocclusion of a coronary vessel completely abolished the postconditioning effects. Their 
results suggested that postconditioning leads to the opening of mKATP channels as a result of 
decreased pH, leading to the attenuation of cardiac infarct size. 
3.3 Reperfusion Survival Kinase Pathway 
The Reperfusion Injury Survival Kinase (RISK) pathway begins with the activation of PI3K 
and ERK to promote cell survival. RISK can be activated by insulin, urocortin, atorvastatin, 
adenosine, bradykinin, opioid agonists, volatile anesthetics, or diazoxide (Bell & Yellon, 
2003a,b; Chiari, et al., 2005; Gross, et al., 2004; Jonassen, et al., 2001; Schulman, et al., 2002; 
Wang, et al., 2004; Yang, et al., 2004). The RISK pathway promotes pro-survival signaling 
while inhibiting pathways associated with apoptosis. In 2004, Tsang and colleagues (2004) 
reported that in isolated rat hearts, which had undergone mechanical postconditioning 
following a period of ischemia, postconditioning is mediated by the PI3K-AKT-
eNOS/p70s6K pathway. They also suggested MEK 1/2-ERK 1/2 pathways were indirectly 
involved. Zhu and coworkers (2006) followed by finding that cardioprotection from 
postconditioning in the remodeled rat myocardium is regulated through PI3K-AKT 
signaling. The role of ERK 1/2 was addressed by Darling et al. (2005) and Krolikowski et al. 
(2006). Darling and colleagues utilized mechanical postconditioning in isolated rabbit hearts 
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and found ERK1/2 but not PI3K activity provided cardiac protection. Krolikowski and 
colleagues exposed rabbits to isoflurane before and during early reperfusion and suggested 
a central role of ERK1/2, p70s6k, and eNOS in anesthetic-induced postconditioning. 
Downstream in the RISK pathway, phosphorylation of AKT occurs with the subsequent 
phosphorylation of protein kinase C (PKC) and GSKβ. When PKC is phosphorylated it is 
stimulated while the phosphorylation of GSKβ inhibits its activity. In a rabbit model, 
Philipp and colleagues (2006) demonstrated through inhibitor studies that adenosine, PKC, 
and PI3K mediated the effects of mechanical postconditioning. In their investigation, they 
concluded that protection was conferred through the activation of adenosine receptors by 
endogenous adenosine, a cellular metabolite. This, in turn, activated the PI3K component of 
the RISK pathway resulting in activation of PKC. In regards to GSKβ, Feng and colleagues 
(2005), using isoflurane as a postconditioning trigger along with an AKT inhibitor, showed 
that when inhaled early in reperfusion, isoflurane phosphorylated AKT and GSKβ. 
Phosphorylated GSKβ was inhibited and could not promote the opening of mPTP. They also 
determined that while the PI3K-AKT signal was strong, the ERK1/2-p38 MAPK was not 
altered. This suggests a primary role of PI3K-AKT in the RISK pathway and in mPTP 
closure. Recently, in human tissue, it has been found that the cytoprotective proteins, HSP25 
and HSP70, are upregulated by the PI3K-AKT pathway (Dickson, et al., 2001). 
3.4 The heat shock response 
Both preconditioning and postconditioning upregulate proteins identified as Heat Shock 
Proteins (HSPs), specifically HSP25 and HSP70. The heat shock response was discovered in 
1962. Drosophilia larvae, when heated, developed puffing patterns in certain chromosomal 
regions. This suggested a change in the synthetic activity of the chromosomal bands 
concerned (Ritossa, 1962). Sixteen years later, the RNA for Drosophilia exposed to a thermal 
stimulus was coded using hybrid-arrested translation and indicated that proteins of 83, 72, 
70, 68, 28, 26, 23 and 22 kilodaltons were upregulated (Livak, et al., 1978). Over the 
following decades, the investigation of the heat shock response has confirmed that a family 
of highly conserved HSPs is upregulated following a variety of sublethal stressors, possibly 
as a result of non-native proteins accumulating in a stressed cell (Voellmy & Boellmann, 
2007). These proteins are subcategorized by their molecular weight and are either inherently 
present or can be induced following sublethal stress (O’Sullivan, et al., 2008). In particular, 
HSP25 and HSP70 have been thoroughly investigated with the consensus being they are 
protective when upregulated following stress (Beere, et al., 2000; Garrido, et al., 2006; 
Takayama, et al., 2003). 
3.4.1 Heat Shock Protein 25/27 
HSP25 is the rodent equivalent of the primate HSP27 and often the terms are used 
interchangeably. HSP27 confers protection at different levels as it can interact with several 
proteins implicated in cell death based upon its phosphorylation and oligomerization 
condition and not upon ATP. The main mechanisms for how HSP27 confers cytoprotection 
appear to be: molecular chaperoning, interference with cell death pathways, signaling of 
antiapoptotic pathways, stabilization of the cytoskeleton, and antioxidant activities. Serving 
as a chaperone, HSP27 can bind folded intermediate non-native proteins, inhibiting their 
aggregation, and in the presence of HSP70 these HSP27-bound proteins can be reactivated 
(Ehrnsperger, et al., 1997). Within the cytosol, HSP27 can sequester cytochrome C; 
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interfering with the formation of the apoptotic protease activating factor-1 (APAF-1)-
cytochrome c multimeric apoptosome and the activation of procaspase 9 (Bruey, et al., 2000; 
Concannon, et al., 2001; Garrido, et al., 1999). HSP27 also directly interacts with procaspase-
3, decreasing the activity of activated caspase-3 (Concannon, et al., 2001). HSP27 serves as a 
signaling messenger by causing the activation of serine/threonine kinase Akt thereby 
inhibiting Bcl-2 and caspase-9 (Cardone, et al., 1998). HSP25/27 has other actions. 
Phosphorylated HSP27 can stabilize F-actin and increase the number of cells retaining 
microfilament organization thus stabilizing membrane structure (Lavoie, et al., 1995). 
Additionally, HSP27 is able to increase glutathione levels, thereby reducing levels of ROS 
(Kretz-Remy, et al., 1996). 
3.4.2 Heat Shock Protein 70 
Over the last three decades, HSP70 has become the most thoroughly investigated protein of 
the HSP family of proteins. Like HSP25, HSP70 can inhibit cell death at various sites within 
the cell. However, unlike HSP25, HSP70 function is “ATP-dependent.” HSP70 is typically 
found in vivo bound by ATP and HSP70 function is typically based upon the hydrolysis of 
the attached ATP molecule. HSP70 serves as a chaperone protein, inhibits stress signaling, 
prevents mitochondrial membrane permeabilization, and inhibits apoptotic pathways. 
HSP70 may chaperone kinases by binding to an unfolded carboxyl terminus, preventing 
aggregation, and allowing re-autophosphorylation of the kinase enzyme; thus stabilizing the 
enzyme and restoring function (Gao & Newton, 2002). HSP70 also binds the death receptors, 
DR4 and DR5, inhibiting Apo-2L/TRAIL-induced cell death (Guo, et al., (2005), and HSP70 
blocks Bax translocation into the mitochondrial outer membrane. The latter effect prevents 
the permeabilization of the mitochondrial membrane and subsequent release of apoptosis-
inducing factor (AIF) and cytochrome C (Stankiewicz , et al., 2005). HSP70 binds AIF within 
the cytosol; inhibiting its nuclear translocation and limiting nuclear condensation 
(Ruchalski, et al., 2006). Similar to HSP25, HSP70 prevents cell death by binding to Apaf-1 
and interfering in the formation of the apoptosome complex and subsequent recruitment of 
procaspase-9 (Beere, et al., 2000). Lastly, HSP70 suppresses apoptotic signaling by binding 
precursor forms of caspase-3 and caspase-7; preventing their cleavage and activation 
(Komarova, et al., 2004). 
3.5 Cleaved caspase 3 
Both HSP25 and HSP70 inhibit the cleavage of caspase-3 (Concannon, et al., 2001; 
Komarova, et al., 2004). Cleaved caspase-3 (CC3) is a primary executioner of apoptosis as it 
is responsible for the total or partial proteolytic cleavage of numerous key cellular survival 
proteins (Fernandes-Alnemri , et al., 1994). One of those proteins being the abundant nuclear 
enzyme polymerase, which functions in DNA repair and protein modification during 
oxidative stress (Smith, 2001). Thus, induction of HSP25 and HSP70 may alleviate cerebral 
ischemic injury and resuscitation injury that results from the mitochondrial release of 
cytochrome C with subsequent cleavage of caspase-3. 
4. Evidence of preconditioning and postconditioning in the brain 
Wu and colleagues (Wu, et al., 2006) directly examined the roles of mPTP and the mKATP 
channel in preconditioning and postconditioning in a rat model of cerebral stroke. These 
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investigators activated the mKATP channel with diazoxide 20 minutes before middle cerebral 
artery occlusion followed by reperfusion, or inhibited the mPTP by infusion of cyclosporin 
A 15 minutes before reperfusion. It was discovered that both measures significantly 
increased functional performance scores and reduced infarction volumes. Importantly, both 
of these effects were abolished by blocking the adenine nucleotide port located on the 
mPTP. Their results strongly suggested that the mKATP channel and mPTP activity during 
reperfusion share a common protective pathway; the Reperfusion Survival Kinase Pathway 
(RISK). More recently, Feng, Rhodes, and Bhatt (2010) discovered that hypoxic 
preconditioning could invoke neuroprotection through the activation of AKT, a kinase that 
is part of the aforementioned RISK pathway. These investigators subjected newborn rats to 3 
hours of 8% oxygen followed by 24 hours of reoxygenation. Following reoxygenation, the 
right carotid artery was permanently ligated and again the rats were subjected to 8% oxygen 
but for 140 minutes instead of 3 hours. Compared to rats subjected to normoxia prior to 
carotid ligation, preconditioned rats had a significant reduction in cerebral injury. It was 
found that preconditioning preserved RISK pathway signaling and attenuated caspase-3 
activity. 
Acute models of postconditioning have emphasized the benefit of cerebral reperfusion 
under controlled conditions. For example, several groups have shown that carefully 
controlled periods of reperfusion, before the full return of cerebral circulation, results in 
reduced injury. Zhao and colleagues (2006) employed permanent middle cerebral artery 
occlusion in combination with transient common carotid artery occlusions. Shorter periods 
of repeated common carotid occlusion resulted in a reduction in infarct size. Pignataro, et al. 
(2008) also employed middle cerebral artery occlusion for 100 minutes. Reperfusion of the 
artery that included a 10-minute period of occlusion was found to be the most effective, 
although intermittent occlusions were also beneficial. Gao, Ren and Zhao (2008) found that 
three cycles of reperfusion of the common carotid artery, in conjunction with permanent 
middle artery occlusion, reduced infarct size, while ten cycles was not effective. These 
publications, as well as numerous reports with cardiac models, emphasis the criticality of 
the duration of cerebral ischemia (longer periods of ischemia result in more cerebral 
damage, including irreversibility), as well as the essential specifics of the timing, duration, 
number of cycles, and inter-reperfusion intervals for effective postconditioning. 
As well, recent work has shown the benefit of pharmacological postconditioning in cerebral 
ischemia. O’Sullivan and colleagues (2007) employed a rat model of combined hemorrhagic 
shock and permanent unilateral common carotid artery occlusion. The administration of 
diazoxide at the time of hemorrhagic resuscitation significantly increased the expression of 
heat shock proteins in the cerebral cortex and hippocampus. Robin and colleagues (2011), 
using a middle cerebral artery occlusion model, found that in Wistar strain rats ischemic 
postconditioning decreased infarct size by 40% and improved neurological outcomes. 
Specifically, pharmacological postconditioning by diazoxide administration decreased 
cerebral infarct by 60%. In addition, these beneficial effects in both ischemic 
postconditioning and diazoxide postconditioning were blocked through the use of the KATP 
blocker, 5-hydroxydecanoate (5-HD), which blocked the inhibition of the mPTP opening 
caused by ischemic postconditioning and diazoxide. 
In 2011, Wang and colleagues discovered that selective delta opioid peptide [D-Ala2, D-
Leu5] enkephalin (DADLE) provided a postconditioning effect by protecting hippocampal 
CA1 neurons in a model of forebrain ischemia. In this investigation, DADLE triggered 
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postconditioning neuroprotection for hippocampal CA1 neurons and improved spatial 
learning and memory in rats. This protection was dependent upon DADLE-induced 
activation of the PI3K/Akt signaling. 
5. Conclusion 
As reviewed, the majority of research related to pre- and post-conditioning has not been 
performed in studies related to cerebral ischemia. As recently stated by Keep and colleagues 
(2010), the question remains—“Is there a place for cerebral preconditioning in the clinic?“ 
The clinical utility of cerebral conditioning is potentially limited by issues of safety, the 
relatively narrow therapeutic window, and the need to present the stimulus before the 
injury. 
Brief periods of ischemia can enact classical and delayed conditioning. These momentary 
periods of ischemia have been shown to protect neuronal cells in vitro and to reduce injury 
in vivo in several experiment models and species (Koch, 2010). Since safety issues prevent 
deliberately inducing conditioning by cerebrovascular occlusion, research has focused on 
pharmacological agents, including volatile anesthetics, inhibitors of cellular metabolism, 
KATP channel activators, and inflammatory mediators (Keep, et al., 2010). Other agents that 
have been effective in producing conditioning are hyperbaric oxygen, cooling and 
hyperthermia, and acupuncture (Keep, et al., 2010). Recent research has also given credence 
to remote conditioning where ischemia to a hindlimb (e.g., by application of a tourniquet) 
protects the brain from later middle cerebral artery occlusion. Remote preconditioning or 
ischemia probably has the most practical use for clinical utilization. However, currently 
there are no clinical data to strongly support the use of any type of conditioning for brain 
protection. 
From a clinical standpoint, a major problem with the application of conditioning is timing. 
With the exception of a planned neurosurgical intervention, classically employed technique 
such as vascular clamping is impractible as a pretreatment. Pharmacological agents, then. 
Given at the time of reperfusion may hold promise. Agents such as MgSO4, erythropoietin, 
anti-hypertension drugs, anticoagulants, and statins all given to patients at risk for stroke 
have shown limited damage from a stroke should it occur (Keep, et al., 2010). 
In addition, there is still little clinical evidence from basic research regarding the use of 
preconditioning for neuroprotection. Research models currently in use have at least four 
important limitations. First, experiments are routinely conducted on young, disease-free 
animals (Koch, 2010). The majority of patients who suffer cerebral ischemic events are older, 
and may have artherosclerosis, cardiac or kidney disease, or other co-morbidities, such as 
obesity, hypertension, diabetes, as well as additional risk factors such as sedentary lifestyle, 
and tobacco, alcohol, or illicit drug abuse. The ‘chronic’ ischemic state of these patients, with 
a chronic conditioning compensatory state, may not allow further conditioning protection 
with interventions. Secondly, both Keep, et al. (2010) and Koch (2010) noted that the effect of 
medications used by patients has a potential to interfere with preconditioning effects. Do 
certain prescribed medications or self-administered substances such as herbal products 
interfere with the conditioning signaling pathways? Third, the neuroprotective cascade 
might be very specific to gender, diet, genetic background, and age (Dirnagl, et al., 2009). 
Lastly, major issues to be resolved include determination of doses of preconditioning drugs 
that are safe and whether premorbid conditions, for example intermittent transient ischemic 
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events, act as a conditioning stimulus event (Dirnagl, et al., 2009; Keep, et al., 2010; Koch, 
2010). 
Finally, optimal neuroprotection may be a combination of physiological manipulations (e.g., 
body temperature regulation) and pharmacological treatment(s). Gidday (2010) provides an 
excellent overview of the current state of pharmacological approaches for neuroprotection. 
Related to the present review, the translational possibilities require continued bench science 
to characterize the signal transduction pathways mediating neuroprotection, and whether or 
not they have potential clinical applicability. There are many “gaps” in understanding the 
mechanisms of action of the >20 drugs presently known to be beneficial (Gidday, 2010), and 
we must determine how best to employ these agents. 
The landmark study by Murry and colleagues on cardiac tissue heralded new and exciting 
research regarding classic and delayed and remote preconditioning as well as the more 
clinically important postconditioning effect. Research continues with pharmacological or 
physical manipulations that can mimic pre- or post- conditioning and this could eventually 
have significant clinical ramifications. Further work is needed that considers the 
aforementioned limitations. Reducing the long-term effect of stroke or traumatic brain 
injury by preserving ischemic tissue can vastly improve the quality of life for patients. 
Likewise, billions of dollars saved from long-term care requirements, lost wages, family 
care-giver issues, and the reduced burden on our health care system will all stand to benefit 
from progress in this critical field of study. 
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